An activating immunoreceptor complex formed by NKG2D and DAP10.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Science

• Publication date

  1999-07-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.285.5428.730PMID 10426994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB

  1999cited by this paper
• Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

  1999cited by this paper
• Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB.

  1999cited by this paper
• Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells.

  1998cited by this paper
• NK cell receptors.

  1998cited by this paper
• Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

  1998cited by this paper
• Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium.

  1996cited by this paper
• The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions

  1996cited by this paper
• Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain.

  1996cited by this paper
• Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor.

  1996cited by this paper
• Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)

  1996cited by this paper
• Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C

  1996cited by this paper
• Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C

  1996cited by this paper
• The Ly-49D Receptor Activates Murine Natural Killer Cells

  1996cited by this paper
• CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.

  1995cited by this paper
• Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells

  1994cited by this paper
• Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling

  1994cited by this paper
• DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells

  1991cited by this paper

• Peri-Transfer Glucocorticoid Therapy in Oocyte-Donation IVF Bridging the Immunological Gap

  2026cites this paper
• Human Leukocyte Antigen (HLA) and Tumor Immunity: A Critical Link in Cancer Immunotherapy

  2026cites this paper
• Integrative Roles of NK Receptors and γδ TCRs in γδ T Cell-Mediated Cancer Immunity.

  2026cites this paper
• CAR-NK cells for haematological cancers.

  2025cites this paper
• Designs of NKG2D-based immunotherapeutics for cancer

  2025cites this paper
• Leveraging the heterogeneity of the NK cell repertoire for the development of immunotherapies for acute leukemia

  2025cites this paper
• Natural Killer Cell Receptor Signaling and Activation Depend on Cell Cycle Stages

  2025influential citation
• NKp30 and NKG2D contribute to natural killer cell-mediated recognition of HIV-infected cells

  2025cites this paper
• Engineered natural killer cells for cancer therapy.

  2025cites this paper
• Immunological memory in natural killer cells.

  2025cites this paper
• A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer

  2025cites this paper
• The role of NK cells in regulating tumorimmunity: current state, challenges and future strategies

  2025cites this paper
• Ligands for Intestinal Intraepithelial T Lymphocytes in Health and Disease

  2025cites this paper
• ULBP2 Promotes Tumor Progression by Suppressing NKG2D-Mediated Anti-Tumor Immunity

  2025cites this paper
• Optimizing Natural Killer Cellular Therapy in Acute Myeloid Leukemia.

  2025cites this paper
• Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial

  2025cites this paper
• Engineering TME-gated inducible CAR-T cell therapy for solid tumors.

  2025cites this paper
• NKp30 and NKG2D contribute to natural killer recognition of HIV-infected cells

  2024cites this paper
• Preclinical characterization of Pan-NKG2D ligand-binding NKG2D receptor decoys

  2024cites this paper
• Five decades of natural killer cell discovery

  2024cites this paper
• Interplay between Microbiota and γδ T Cells: Insights into Immune Homeostasis and Neuro-Immune Interactions

  2024cites this paper
• miR-17-5p/STAT3/H19: A novel regulatory axis tuning ULBP2 expression in young breast cancer patients.

  2024cites this paper
• Human decidua basalis mesenchymal stem/stromal cells enhance anticancer properties of human natural killer cells, in vitro

  2024cites this paper
• The activating receptor NKG2D is an anti-fungal pattern recognition receptor

  2024influential citation
• Advancements in the Therapeutic Application of Natural Killer Cells in Acute Myeloid Leukemia

  2024cites this paper
• Challenges in the Development of NK-92 Cells as an Effective Universal Off-the-Shelf Cellular Therapeutic.

  2024cites this paper
• B7H6 is the predominant activating ligand driving natural killer cell-mediated killing in patients with liquid tumours: evidence from clinical, in silico, in vitro, and in vivo studies

  2024cites this paper
• Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives

  2024cites this paper
• The Multifaceted Roles of NK Cells in the Context of Murine Cytomegalovirus and Lymphocytic Choriomeningitis Virus Infections

  2024cites this paper
• Targeting NKG2D/NKG2DL axis in multiple myeloma therapy.

  2024cites this paper
• Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy

  2024cites this paper
• NKG2D receptor signaling shapes T cell thymic education

  2023cites this paper
• The transcription factor Aiolos restrains the activation of intestinal intraepithelial lymphocytes

  2023cites this paper
• Tumor-Infiltrating CD45RO+ Memory Cells Are Associated with Favorable Prognosis in Oral Squamous Cell Carcinoma Patients

  2023cites this paper
• Impact of NKG2D Signaling on Natural Killer and T‐Cell Function in Cerebral Ischemia

  2023cites this paper
• Fluid shear stress enhances natural killer cell's cytotoxicity toward circulating tumor cells through NKG2D-mediated mechanosensing

  2023cites this paper
• Non-coding RNAs: emerging roles in the characterization of immune microenvironment and immunotherapy of prostate cancer.

  2023cites this paper
• Advances in natural killer cell therapies for breast cancer

  2023cites this paper
• Human leukocyte antigen and tumor immunotherapy (Review)

  2023cites this paper
• Identification of small-molecule protein–protein interaction inhibitors for NKG2D

  2023cites this paper
• Facing challenges with hope: universal immune cells for hematologic malignancies

  2023cites this paper
• The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy

  2023cites this paper
• Short tandem repeats are important contributors to silencer elements in T cells

  2023cites this paper
• Receptors of immune cells mediates recognition for tumors.

  2023cites this paper
• Microenvironmental signals shaping NK‐cell reactivity in cancer

  2023cites this paper
• NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cells.

  2023cites this paper
• Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells

  2023influential citation
• Effects of the interactions between platelets with other cells in tumor growth and progression

  2023cites this paper
• Human natural killer cells: form, function, and development.

  2022cites this paper
• STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2Dhi CD8+ T cell dysregulation and accumulation.

  2022cites this paper
• Pore-forming proteins and their role in cancer and inflammation: Mechanistic insights and plausible druggable targets.

  2022cites this paper
• Designing Cancer Immunotherapies That Engage T Cells and NK Cells.

  2022cites this paper
• Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy

  2022cites this paper
• Natural killer cells and acute myeloid leukemia: promises and challenges

  2022cites this paper
• Progress of CAR-T Therapy in Gastric Cancer

  2022cites this paper
• Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression

  2022cites this paper
• Roles and Clinical Application of Exosomes in Prostate Cancer

  2022cites this paper
• Immunotherapeutic Targeting of Activating Natural Killer Cell Receptors and their Ligands in Cancer.

  2022cites this paper
• Lack of NKG2D in MAGT1-deficient patients is caused by hypoglycosylation

  2022cites this paper
• Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell Leukemias

  2022cites this paper
• Phenotypic and Functional Plasticity of CXCR6+ Peripheral Blood NK Cells

  2022cites this paper
• BACH2 restricts NK cell maturation and function, limiting immunity to cancer metastasis

  2022cites this paper
• STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological dysregulation of NKG2Dhi CD8 killer T cells

  2022influential citation
• Uterine natural killer cells and recurrent spontaneous abortion

  2021cites this paper
• Mechanisms of the Effect of Simulated Microgravity on the Cytotoxicity of NK Cells Following the DNA Methylation of NKG2D and the Expression of DAP10

  2021cites this paper
• MICA A5.1 homozygous genotype is associated with a risk for early-onset oral cancer.

  2021cites this paper
• Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation

  2021cites this paper
• Targeting the NKG2D/NKG2D-L axis in acute myeloid leukemia.

  2021cites this paper
• Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors

  2021cites this paper
• CAR T-Cell Therapy with NKG2D Chimeric Antigen Receptor in Relapsed/ Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

  2021cites this paper
• CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway

  2021cites this paper
• NKG2D discriminates diverse ligands through selectively mechano‐regulated ligand conformational changes

  2021cites this paper
• Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors

  2021cites this paper
• Human NKG2D Ligand Regulation of NK Cell Functions and Metabolism: From Molecular Mechanisms to Therapeutics

  2021cites this paper
• Epigenetic regulation of natural killer cell memory *

  2021cites this paper
• Nano-Optogenetic Engineering of CAR T-cells for Precision Immunotherapy with Enhanced Safety

  2021cites this paper
• Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy

  2021cites this paper
• Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen

  2021influential citation
• The low cytotoxic activity of peripheral blood NK cells may relate to unexplained recurrent miscarriage

  2021cites this paper
• Decidual Natural Killer Cells: A Good Nanny at the Maternal-Fetal Interface During Early Pregnancy

  2021cites this paper
• NK Cell Therapy: A Rising Star in Cancer Treatment

  2021cites this paper
• Prediction of late allograft dysfunction following liver transplantation by immunological blood biomarkers.

  2021cites this paper
• Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives

  2021cites this paper
• The Crosstalk Between Dendritic Cells, Cytokine-Induced Killer Cells And Cancer Cells From The Perspective Of Combination Therapy

  2021cites this paper
• Manipulating the NKG2D Receptor-Ligand Axis Using CRISPR: Novel Technologies for Improved Host Immunity

  2021cites this paper
• NK cells and CD8 T cells in cancer immunotherapy: Similar functions by different mechanisms

  2021cites this paper
• Immunopathology of Celiac Disease

  2021cites this paper
• The antigen‐binding moiety in the driver's seat of CARs

  2021cites this paper
• Genetically Engineered Mouse Models Support a Major Role of Immune Checkpoint-Dependent Immunosurveillance Escape in B-Cell Lymphomas

  2021cites this paper
• Regulation of NKG2D by RKIP: Implications on NK-mediated cytotoxicity and cytokine production

  2021cites this paper
• Mechanisms of the Effect of Simulated Microgravity on the Cytotoxicity of NK Cells Following the DNA Methylation of NKG2D and the Expression of DAP10

  2021cites this paper
• MICA/B antibody induces macrophage-mediated immunity against acute myeloid leukemia.

  2021cites this paper
• Enteropathy-Associated T cell Lymphoma

  2021cites this paper
• Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity

  2021cites this paper
• A Chimeric Antigen Receptor That Binds to a Conserved Site

  2020cites this paper
• Role of γδ T Lymphocytes in Cancer Immunosurveillance and Immunotherapy

  2020cites this paper
• Genetic Engineering of Natural Killer Cells for Enhanced Antitumor Function

  2020cites this paper
• NK Cell Interaction With Platelets and Myeloid Cells in the Tumor Milieu

  2020cites this paper
• NKG2D and MICA/B shedding: a ‘tag game’ between NK cells and malignant cells

  2020cites this paper
• Role of Natural Killer Cells in Uveal Melanoma

  2020cites this paper